ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $817,000 | -9.6% | 14,200 | 0.0% | 1.09% | -10.2% |
| Q1 2015 | $904,000 | -0.4% | 14,200 | -3.4% | 1.22% | -4.3% |
| Q4 2014 | $908,000 | +62.4% | 14,700 | +2.1% | 1.27% | +51.2% |
| Q3 2014 | $559,000 | +160.0% | 14,400 | +130.4% | 0.84% | +164.8% |
| Q2 2014 | $215,000 | -68.3% | 6,250 | -60.2% | 0.32% | -70.2% |
| Q1 2014 | $678,000 | -45.3% | 15,700 | -49.5% | 1.07% | -16.5% |
| Q4 2013 | $1,239,000 | +32.2% | 31,100 | +24.6% | 1.28% | +22.9% |
| Q3 2013 | $937,000 | – | 24,950 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
| DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
| WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
| Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
| SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
| Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
| PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
| Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
| PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |